Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways.
Earlier patient access to beneficial therapeutics that address unmet need is one of the main requirements of innovation in global healthcare systems– already burdened by unsustainable budgets. ‘Adaptive pathways’ (1), encompass earlier cross-stakeholder engagement, regulatory tools, and iterative e...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2016
|
| _version_ | 1797068244570341376 |
|---|---|
| author | Faulkner, S Lee, M Qin, D Morrell, L Xoxi, E Sammarco, A Cammarata, S Russo, P Pani, L Barker, R |
| author_facet | Faulkner, S Lee, M Qin, D Morrell, L Xoxi, E Sammarco, A Cammarata, S Russo, P Pani, L Barker, R |
| author_sort | Faulkner, S |
| collection | OXFORD |
| description | Earlier patient access to beneficial therapeutics that address unmet need is one of the main requirements of innovation in global healthcare systems– already burdened by unsustainable budgets. ‘Adaptive pathways’ (1), encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated. |
| first_indexed | 2024-03-06T22:07:56Z |
| format | Journal article |
| id | oxford-uuid:50ca1a7a-8e31-402f-9468-bbcd16e34f46 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:07:56Z |
| publishDate | 2016 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:50ca1a7a-8e31-402f-9468-bbcd16e34f462022-03-26T16:15:43ZPricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:50ca1a7a-8e31-402f-9468-bbcd16e34f46EnglishSymplectic Elements at OxfordWiley2016Faulkner, SLee, MQin, DMorrell, LXoxi, ESammarco, ACammarata, SRusso, PPani, LBarker, REarlier patient access to beneficial therapeutics that address unmet need is one of the main requirements of innovation in global healthcare systems– already burdened by unsustainable budgets. ‘Adaptive pathways’ (1), encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated. |
| spellingShingle | Faulkner, S Lee, M Qin, D Morrell, L Xoxi, E Sammarco, A Cammarata, S Russo, P Pani, L Barker, R Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title | Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title_full | Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title_fullStr | Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title_full_unstemmed | Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title_short | Pricing and reimbursement experiences and insights in the EU and US: Lessons learned to approach adaptive payer pathways. |
| title_sort | pricing and reimbursement experiences and insights in the eu and us lessons learned to approach adaptive payer pathways |
| work_keys_str_mv | AT faulkners pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT leem pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT qind pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT morrelll pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT xoxie pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT sammarcoa pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT cammaratas pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT russop pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT panil pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways AT barkerr pricingandreimbursementexperiencesandinsightsintheeuanduslessonslearnedtoapproachadaptivepayerpathways |